← Open Payments lookup

DARLINE DURAND: Open Payments

NPI 1912185455 · BROOKLYN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$557 in 24 payments from 12 companies in 2025. Trend: 2023 $20 · 2024 $256 · 2025 $557

Food & beverage: $557
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP4$106
Merck Sharp & Dohme LLC4$102
Stemline Therapeutics Inc.3$72
PharmaEssentia USA Corporation3$51
Janssen Biotech, Inc.2$49
Takeda Pharmaceuticals U.S.A., Inc.1$33
PUMA BIOTECHNOLOGY, INC.2$33
Boehringer Ingelheim Pharmaceuticals, Inc.1$28
Genentech USA, Inc.1$24
TAIHO ONCOLOGY, INC.1$22

Products named: KEYTRUDA, Orserdu, BESREMI, FRUZAQLA, NERLYNX, CALQUENCE, RYBREVANT, Itovebi.

Industry payments across NY — which companies pay providers there.